Earnings Feed
Start Free
Zomedica Pharmaceuticals Corp.·4

Mar 30, 4:08 PM ET

Morley Stephanie 4

4 · Zomedica Pharmaceuticals Corp. · Filed Mar 30, 2018

Insider Transaction Report

Form 4
Period: 2018-03-29
Zomedica Pharmaceuticals Corp.ZOM
Morley Stephanie
COO & VP of Product Dev
Transactions
  • Exercise/Conversion

    Common Shares, without par value

    2018-03-29$0.20/sh+500,000$100,000→ 1,355,580 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-03-29−500,000→ 600,000 total
    Exercise: $0.20From: 2016-03-28Exp: 2018-04-21→ Common Shares, without par value (500,000 underlying)
Holdings

  • Common Shares, without par value

    (indirect: By daughter)
    1,000

  • Common Shares, without par value

    (indirect: By step-daughter)
    1,000

  • Common Shares, without par value

    (indirect: By step-son)
    1,000

  • Common Shares, without par value

    (indirect: By daughter)
    1,000

  • Common Shares, without par value

    (indirect: By step-son)
    1,000
Footnotes (1)
  • [F1]The options vested upon grant. The option is currently fully vested.

Documents

1 file
  • 4
    zomedica_form4mar292018.xmlPrimary

    OWNERSHIP DOCUMENT